- About About
-
Medical
Medical
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
-
-
ARCHIVE
What's the Cost
For twelve years Americans for Safe Access (ASA) has been tracking the passage and implementation of state medical cannabis (marijuana) laws in the United States and compiling raw data on actions taken by the Department of Justice (DOJ) to thwart implementation efforts with tactics such as raids on individual patients and state-authorized dispensing centers, civil actions against property owners and threats to elected officials. The following report summaries that data in an attempt to reveal the tax-payer cost of enforcing outdated federal policies as well as presenting some examples of the other type of cost, the human cost at the center this unpopular war on medical cannabis.
The data was gathered from individuals calling the organization, DEA press releases, news reports and court records. We do not express that this report represents 100% of the federal activity or the findings are 100% accurate. During the drafting of this report updates had be made to the data to reflect 2 more raids, a series of asset forfeiture threats to landlords in Seattle and three individuals self-surrendering to jail to begin 5 year-mandatory minimum sentences. The authors of the report would welcome alternative numbers presented by the Department of Justice.
The Report Finds
- 34% of Americans live in states with medical marijuana laws and could increase to 39% this year
- Over 1 million Americans are legally using medical cannabis
- This war is being waged on citizens. The report profiles some of the individuals and organizations that are being caught in this war.
- Nation-wide support of state laws has remained at around 70-80% for nearly two-decades
- The cost of the federal governments war on medical cannabis to date is nearly 600 million dollars
- The Obama Administration has out spent the Bush Administration by 120 Million in just 4 ½ years
- Under the Obama Administration, DEA has spent 1-4% % of their budget on the medical cannabis war
- Without Congressional intervention, the amount of funds spent on undermining state laws will only increase
It is our hope that this information can help better guide federal policy makers in addressing this costly issue.
Share